Zentalis Pharmaceuticals, Inc.Zentalis Pharmaceuticals, Inc.Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

33.560.00 0.00%
The 9 analysts offering 1 year price forecasts for ZNTL have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to ZNTL in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ZNTL EPS for the last quarter is −0.86 USD despite the estimation of −0.82 USD. In the next quarter EPS is expected to reach −0.77 USD. Track more of Zentalis Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Zentalis Pharmaceuticals, Inc. revenue is expected to reach ‪15.00 M‬ USD. Check out Zentalis Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, ZNTL price target is 33.56 USD with a max estimate of 50.00 USD and a min estimate of 15.00 USD. Check if this forecast comes true in a year, meanwhile watch Zentalis Pharmaceuticals, Inc. stock price chart and keep track of the current situation with ZNTL news and stock market news.
We've gathered opinions of 10 analysts rating ZNTL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.